Financial Post
🏢 Postmedia
📍 BC
Jul 16, 2026
· 1 min read
AI Analyzed
○ Unverifiable
View full audit trail →
Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026
Original article ↗ 🔒 Paywalled source — limited preview availableB.I.A.S. ANALYSIS
RIGHT
LEFTCENTERRIGHT
Signal breakdown
Heuristic (v1/v3)
1.00 · RIGHT
🏦 Source Intelligence
Rolling outlet bias
CENTER
avg -0.027
2,911 articles tracked
7-day bias trend
LcenterR
V.E.R.I.F.Y. has fact-checked this article.
Subscribe to see claim-by-claim verdicts and reasoning.
Subscribe to see claim-by-claim verdicts and reasoning.
Article Excerpt
VANCOUVER, British Columbia, July 16, 2026 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that management will report its second quarter 2026 financial results after market close on August 6, 2026. In light of the […]
Read full article at Financial Post ↗
How we scored this article
WTF uses a two-tier system: every article gets a heuristic bias score from keyword analysis, and priority articles (high overlap across 3+ outlets or strong heuristic signal) get full LLM analysis from B.I.A.S. and V.E.R.I.F.Y.
Analyzed by
B.I.A.S.
V.E.R.I.F.Y.
L.O.C.A.L.
pending
Jul 16, 2026